Literature DB >> 29748627

Deficient endocannabinoid signaling in the central amygdala contributes to alcohol dependence-related anxiety-like behavior and excessive alcohol intake.

Antonia Serrano1,2, Francisco J Pavon3,4, Matthew W Buczynski3, Joel Schlosburg5, Luis A Natividad3, Ilham Y Polis3, David G Stouffer3, Eric P Zorrilla3, Marisa Roberto3, Benjamin F Cravatt6, Rémi Martin-Fardon7, Fernando Rodriguez de Fonseca8, Loren H Parsons3.   

Abstract

Negative emotional states that are associated with excessive alcohol intake, particularly anxiety-like states, have been linked to opponent processes in the central nucleus of the amygdala (CeA), affecting stress-related transmitters and monoamines. This study extends these observations to include endocannabinoid signaling in alcohol-dependent animals. Rats and mice were exposed to chronic intermittent alcohol with vapor inhalation or liquid diet to induce dependence. In vivo microdialysis was used to estimate interstitial concentrations of endocannabinoids [N-arachidonoylethanolamine (anandamide; AEA) and 2-arachidonoylglycerol (2-AG)] and amino acids (glutamate and GABA) in rat CeA. Additionally, we evaluated the inhibition of endocannabinoids clearance enzymes [monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase] on anxiety-like behavior and alcohol consumption in alcohol-dependent rats and mice. Results revealed that alcohol dependence produced decreases in baseline 2-AG dialysate levels and increases in baseline levels of glutamate and GABA. Acute alcohol abstinence induced an enhancement of these dependence-induced effects and the levels of 2-AG and GABA were restored upon alcohol re-exposure. Additional studies showed that the increased CeA 2-AG levels induced by restraint stress and alcohol self-administration were blunted in alcohol-dependent rats. Pharmacological studies in rats and mice showed that anxiety-like behavior and alcohol consumption were increased in alcohol-dependent animals, and these behavioral effects were attenuated mainly by MAGL inhibitors [MJN110 (10 and 20 mg/kg) in rats and JZL184 (1 and 3 mg/kg) in mice]. The present results suggest a key role for endocannabinoid signaling in motivational neuroadaptations during alcohol dependence, in which a deficiency in CeA 2-AG signaling in alcohol-dependent animals is linked to stress and excessive alcohol consumption.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29748627      PMCID: PMC6046053          DOI: 10.1038/s41386-018-0055-3

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  67 in total

1.  Differential effects of single versus repeated alcohol withdrawal on the expression of endocannabinoid system-related genes in the rat amygdala.

Authors:  Antonia Serrano; Patricia Rivera; Francisco J Pavon; Juan Decara; Juan Suárez; Fernando Rodriguez de Fonseca; Loren H Parsons
Journal:  Alcohol Clin Exp Res       Date:  2011-12-05       Impact factor: 3.455

2.  CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents.

Authors:  J Haller; B Varga; C Ledent; T F Freund
Journal:  Behav Pharmacol       Date:  2004-07       Impact factor: 2.293

3.  Corticosteroid-dependent plasticity mediates compulsive alcohol drinking in rats.

Authors:  Leandro F Vendruscolo; Estelle Barbier; Joel E Schlosburg; Kaushik K Misra; Timothy W Whitfield; Marian L Logrip; Catherine Rivier; Vez Repunte-Canonigo; Eric P Zorrilla; Pietro P Sanna; Markus Heilig; George F Koob
Journal:  J Neurosci       Date:  2012-05-30       Impact factor: 6.167

Review 4.  Endocannabinoid-mediated control of synaptic transmission.

Authors:  Masanobu Kano; Takako Ohno-Shosaku; Yuki Hashimotodani; Motokazu Uchigashima; Masahiko Watanabe
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

Review 5.  Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.

Authors:  Antonia Serrano; Loren H Parsons
Journal:  Pharmacol Ther       Date:  2011-07-18       Impact factor: 12.310

6.  Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB₁ receptor blockade.

Authors:  Luigi Bellocchio; Edgar Soria-Gómez; Carmelo Quarta; Mathilde Metna-Laurent; Pierre Cardinal; Elke Binder; Astrid Cannich; Anna Delamarre; Martin Häring; Mar Martín-Fontecha; David Vega; Thierry Leste-Lasserre; Dusan Bartsch; Krisztina Monory; Beat Lutz; Francis Chaouloff; Uberto Pagotto; Manuel Guzman; Daniela Cota; Giovanni Marsicano
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-04       Impact factor: 11.205

Review 7.  Neuropeptide modulation of central amygdala neuroplasticity is a key mediator of alcohol dependence.

Authors:  Nicholas W Gilpin; Marisa Roberto
Journal:  Neurosci Biobehav Rev       Date:  2011-11-11       Impact factor: 8.989

8.  Sex differences in alcohol consumption and alterations in nucleus accumbens endocannabinoid mRNA in alcohol-dependent rats.

Authors:  Angela M Henricks; Anthony L Berger; Janelle M Lugo; Lydia N Baxter-Potter; Kennedy V Bieniasz; Rebecca M Craft; Ryan J McLaughlin
Journal:  Neuroscience       Date:  2016-08-27       Impact factor: 3.590

9.  Corticotropin releasing factor-induced amygdala gamma-aminobutyric Acid release plays a key role in alcohol dependence.

Authors:  Marisa Roberto; Maureen T Cruz; Nicholas W Gilpin; Valentina Sabino; Paul Schweitzer; Michal Bajo; Pietro Cottone; Samuel G Madamba; David G Stouffer; Eric P Zorrilla; George F Koob; George R Siggins; Loren H Parsons
Journal:  Biol Psychiatry       Date:  2010-01-08       Impact factor: 13.382

10.  Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects.

Authors:  Jonathan Z Long; Weiwei Li; Lamont Booker; James J Burston; Steven G Kinsey; Joel E Schlosburg; Franciso J Pavón; Antonia M Serrano; Dana E Selley; Loren H Parsons; Aron H Lichtman; Benjamin F Cravatt
Journal:  Nat Chem Biol       Date:  2008-11-23       Impact factor: 15.040

View more
  26 in total

Review 1.  Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.

Authors:  George F Koob
Journal:  Pharmacol Rev       Date:  2021-01       Impact factor: 25.468

2.  Ethanol-induced alterations in endocannabinoids and relevant neurotransmitters in the nucleus accumbens of fatty acid amide hydrolase knockout mice.

Authors:  Francisco J Pavón; Antonia Serrano; David G Stouffer; Ilham Polis; Marisa Roberto; Benjamin F Cravatt; Rémi Martin-Fardon; Fernando Rodríguez de Fonseca; Loren H Parsons
Journal:  Addict Biol       Date:  2018-11-13       Impact factor: 4.280

3.  COX-2 Inhibition Antagonizes Intra-Accumbens 2-Arachidonoylglycerol-Mediated Reduction in Ethanol Self-Administration in Rats.

Authors:  Francisco J Pavon; Ilham Polis; David G Stouffer; Marisa Roberto; Rémi Martin-Fardon; Fernando Rodriguez de Fonseca; Loren H Parsons; Antonia Serrano
Journal:  Alcohol Clin Exp Res       Date:  2020-10-03       Impact factor: 3.455

4.  Cessation of fluoxetine treatment increases alcohol seeking during relapse and dysregulates endocannabinoid and glutamatergic signaling in the central amygdala.

Authors:  Juan Suárez; Sophia Khom; Francisco Alén; Luis A Natividad; Florence P Varodayan; Reesha R Patel; Dean Kirson; Rocío Arco; Antonio Ballesta; Michal Bajo; Leticia Rubio; Rémi Martin-Fardon; Fernando Rodríguez de Fonseca; Marisa Roberto
Journal:  Addict Biol       Date:  2019-07-24       Impact factor: 4.280

5.  Cannabis and Alcohol: From Basic Science to Public Policy.

Authors:  Tammy Chung; R Adron Harris
Journal:  Alcohol Clin Exp Res       Date:  2019-07-25       Impact factor: 3.455

Review 6.  Distinct functions of endogenous cannabinoid system in alcohol abuse disorders.

Authors:  Balapal S Basavarajappa; Vikram Joshi; Madhu Shivakumar; Shivakumar Subbanna
Journal:  Br J Pharmacol       Date:  2019-07-29       Impact factor: 8.739

Review 7.  Endocannabinoid Signaling in the Central Amygdala and Bed Nucleus of the Stria Terminalis: Implications for the Pathophysiology and Treatment of Alcohol Use Disorder.

Authors:  Gaurav Bedse; Samuel W Centanni; Danny G Winder; Sachin Patel
Journal:  Alcohol Clin Exp Res       Date:  2019-08-21       Impact factor: 3.455

Review 8.  2-Arachidonoylglycerol Modulation of Anxiety and Stress Adaptation: From Grass Roots to Novel Therapeutics.

Authors:  Gaurav Bedse; Mathew N Hill; Sachin Patel
Journal:  Biol Psychiatry       Date:  2020-03-17       Impact factor: 13.382

9.  Contribution of Fatty Acid Amide Hydrolase to Alcohol Use Disorder: A Systematic Review.

Authors:  Greta Niemela; Garth E Terry
Journal:  Cannabis Cannabinoid Res       Date:  2021-04-05

10.  Endocannabinoid contributions to alcohol habits and motivation: Relevance to treatment.

Authors:  Carol A Gianessi; Stephanie M Groman; Summer L Thompson; Ming Jiang; Mario van der Stelt; Jane R Taylor
Journal:  Addict Biol       Date:  2019-05-06       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.